Skip to content

Clinical trials

Parkinson Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Country / region: Italy Clear all

337 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20044
20054
20069
20079
20081
20094
20109
20115
20124
201313
201416
201520
20169
201720
201817
201929
202018
202131
202229
202326
202413
202528
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed158
Unknown status68
Recruiting59
Active, not recruiting19
Terminated16
Not yet recruiting11
Enrolling by invitation4
Withdrawn1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ospedale Generale Di Zona Moriggia-Pelascini20
IRCCS San Raffaele Roma18
Fondazione Don Carlo Gnocchi ETS15
Neuromed IRCCS14
IRCCS Centro Neurolesi Bonino Pulejo13
Fondazione Policlinico Universitario Agostino Gemelli IRCCS12
AbbVie8
IRCCS San Camillo, Venezia, Italy8
Istituto Auxologico Italiano8
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease337
Multiple Sclerosis26
Stroke25
Movement Disorders21
Parkinsonian Disorders20
Neurodegenerative Diseases17
Nervous System Diseases16
Cognitive Dysfunction15
Alzheimer Disease12
Dyskinesias11

Trials

Showing 51 to 75 of 337. Each trial links to its page on Pharma Observatory.

237 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.